Recorded fact · drug.label_indication
drug.label_indication for pembrolizumab|hodgkin-lymphoma
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 877911ad resolves to.
The record
| Fact id | 877911adafd5eaeef4a8bc9a |
|---|---|
| Entity | drug: pembrolizumab|hodgkin-lymphoma |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260710 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Classical Hodgkin Lymphoma (cHL) for the treatment of adult patients with relapsed or refractory cHL.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: a0402f0757b0fed0d55fa5dc2d07039bbd53ad85afe33ef4e63240dfc66413e1.
The value
{
"ingredient": "Pembrolizumab",
"conditionId": "hodgkin-lymphoma",
"conditionName": "Hodgkin Lymphoma",
"matchedAlias": "Hodgkin Lymphoma",
"context": "indication",
"brand": "KEYTRUDA",
"identifiedVia": "product_elements",
"extractor": 5,
"labelSetId": "9333c79b-d487-4538-a9f0-71b91a02b287",
"labelEffectiveTime": "20260710",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: bbc2e49286000534d93df176d9f07958b9cc013143548c6a6128119f6827a1cc.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.